Form D · Biotechnology
Willow Neuroscience, Inc.
Palo Alto, CA · CIK 0001701524
Offering snapshot reported Jul 10, 2023 · SEC filing
- Reported sold
- $2.07M Offering amount: $3.25M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 6, 2016 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$2,024,500 → $2,074,500
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 10, 2023 | Amendment | $2,074,500 | $50,000vs Jan 18, 2022 | 19 | SEC filing |
| Jan 18, 2022 | Initial | $2,024,500 | No comparison | 19 | SEC filing |
| Apr 5, 2017 | Initial | $25,200 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-429648
Source: Form D, filed Jul 10, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Katrin I. Andreasson | Director |
| Mark P. De Souza | Director, Executive |
| Michelle L. James | Director |
| John Kincaid | Director, Executive |
| Michael C. Venuti | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Palo Alto, CA, 94304
Phone: 510-588-8840